FGH10019


CAS No. : 1046045-61-7

1046045-61-7
Price and Availability of CAS No. : 1046045-61-7
Size Price Stock
5mg $330 In-stock
10mg $480 In-stock
50mg $1440 In-stock
100 mg Get quote
200 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-16207
M.Wt: 373.49
Formula: C18H19N3O2S2
Purity: >98 %
Solubility: DMSO : ≥ 38 mg/mL
Introduction of 1046045-61-7 :

FGH10019 is a novel sterol regulatory element-binding protein (SREBP) inhibitor with IC50 of 1 μM. IC50 & Target: IC50: 1 μM (SREBP) In Vitro: Treatment of the CHO-K1 cells with analog FGH10019 decreases the percentage of the mature form of SREBP-2 (68 kDa) at lower concentrations than treatment with fatostatin. Densitometric analysis of the gels indicates that the IC50 of analog FGH10019 is approximately 1 μM, which is 5-10 times lower than the IC50 of fatostatin (appr 10 μM)[1]. In Vivo: FGH10019-treated chow is fed at a dose rate calculated to provide about 0.7 mg analog FGH10019 per day, at about 23 mg/kg body weight, to 5-wk-old male ob/ob mice weighing an average of appr 30 g. After 8 wk on the analog 24-treated chow, the mice gain 8-9 % less weight than control mice[1].

Your information is safe with us.